McIlrath & Eck Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.95M |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.26M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$489K |
| 4 |
Vanguard Real Estate ETF
VNQ
|
+$462K |
| 5 |
PACCAR
PCAR
|
+$220K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$452K |
| 2 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$242K |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$74.9K |
| 4 |
UMH
UMH Properties
UMH
|
+$52.6K |
| 5 |
Marathon Petroleum
MPC
|
+$51.4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.12% |
| 2 | Financials | 2.19% |
| 3 | Communication Services | 1.61% |
| 4 | Consumer Discretionary | 1.59% |
| 5 | Consumer Staples | 1.58% |
Similar funds
McIlrath & Eck's Q4 2019 Portfolio in Review
As of Q4 2019, McIlrath & Eck held 684 positions worth $208M, up 10% from $189M the previous quarter. Its ten largest holdings account for 85% of the portfolio.
McIlrath & Eck deployed $8.01M of net new capital in Q4 2019, opening 34 new positions and adding to 115 existing holdings. Its largest new stake was iShares Biotechnology ETF: 512 shares worth $62K.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 8.5% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Vanguard Morningstar Growth ETF, an estimated $452K trimmed.
- McIlrath & Eck's largest Q4 2019 buy was iShares Biotechnology ETF: 512 shares worth $62K.
- McIlrath & Eck added most to Microsoft in Q4 2019, an estimated $3.95M increase.
- McIlrath & Eck's biggest Q4 2019 reduction was Vanguard Morningstar Growth ETF, cutting an estimated $452K.
- McIlrath & Eck fully exited Celgene Corp in Q4 2019, selling an estimated $48K.
- McIlrath & Eck's ten largest holdings make up 85% of its $208M portfolio in Q4 2019.
- McIlrath & Eck opened 34 new positions and closed 28 in Q4 2019.
- McIlrath & Eck's portfolio value rose 10% quarter-over-quarter to $208M.
Based on McIlrath & Eck's 13F filing for Q4 2019, filed 11 Feb 2020.